TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 2.5B 5B 7.5B Q3 '16: 5.6B Q4 '16: 6.5B Q1 '17: 5.7B Q2 '17: 5.7B Q3 '17: 5.6B Q4 '17: 5.4B Q1 '18: 5.1B Q2 '18: 4.7B Q3 '18: 4.5B Q4 '18: 4.4B Q1 '19: 4.1B Q2 '19: 4.2B Q3 '19: 4.1B Q4 '19: 4.5B Q1 '20: 4.4B Q2 '20: 3.9B Q3 '20: 4B Q4 '20: 4.5B Q1 '21: 4B Q2 '21: 3.9B Q3 '21: 3.9B Q4 '21: 4.1B Q1 '22: 3.7B Q2 '22: 3.8B Q3 '22: 3.6B Q4 '22: 3.9B Q1 '23: 3.7B Q2 '23: 3.9B Q3 '23: 3.9B Q4 '23: 4.5B Q1 '24: 3.8B Q2 '24: 4.2B Q3 '24: 4.3B Q4 '24: 4.2B Q1 '25: 3.9B Q2 '25: 4.2B Q3 '25: 4.5B Q4 '25: 4.7B Q1 '26: 4B Q2 '26: 4.1B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Gross Profit Quarterly

0 1.5B 3B 4.5B Q3 '16: 2.8B Q4 '16: 3.4B Q1 '17: 2.8B Q2 '17: 2.9B Q3 '17: 2.6B Q4 '17: 2.4B Q1 '18: 2.3B Q2 '18: 2B Q3 '18: 2B Q4 '18: 2B Q1 '19: 1.9B Q2 '19: 1.9B Q3 '19: 1.8B Q4 '19: 2B Q1 '20: 2.1B Q2 '20: 1.8B Q3 '20: 1.9B Q4 '20: 2B Q1 '21: 1.9B Q2 '21: 1.9B Q3 '21: 1.8B Q4 '21: 2B Q1 '22: 1.7B Q2 '22: 1.8B Q3 '22: 1.7B Q4 '22: 1.8B Q1 '23: 1.6B Q2 '23: 1.8B Q3 '23: 1.9B Q4 '23: 2.4B Q1 '24: 1.8B Q2 '24: 2B Q3 '24: 2.1B Q4 '24: 2.1B Q1 '25: 1.9B Q2 '25: 2.1B Q3 '25: 2.3B Q4 '25: 2.7B Q1 '26: 2B Q2 '26: 2.2B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Income Quarterly

-15B -10B -5B 0 5B 10B 15B Q2 '16: 361M Q3 '16: 765M Q1 '17: 895M Q2 '17: -5.7B Q3 '17: 378M Q4 '17: -13B Q1 '18: 1.5B Q2 '18: -14M Q3 '18: 16M Q4 '18: -3.2B Q1 '19: 134M Q2 '19: -644M Q3 '19: -81M Q4 '19: 148M Q1 '20: 191M Q2 '20: 173M Q3 '20: -4.3B Q4 '20: 406M Q1 '21: 434M Q2 '21: 582M Q3 '21: 623M Q4 '21: 78M Q1 '22: -713M Q2 '22: -949M Q3 '22: 419M Q4 '22: -940M Q1 '23: -13M Q2 '23: -654M Q3 '23: 344M Q4 '23: 756M Q1 '24: -218M Q2 '24: -5M Q3 '24: -51M Q4 '24: -29M Q1 '25: 519M Q2 '25: 455M Q3 '25: 882M Q4 '25: 300M Q1 '26: 652M Q2 '26: -231M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Net Income Quarterly

-12B -8B -4B 0 4B 8B 12B Q1 '16: 636M Q2 '16: 254M Q3 '16: 412M Q1 '17: 645M Q2 '17: -6B Q3 '17: 595M Q4 '17: -11.5B Q1 '18: 1.1B Q2 '18: -176M Q3 '18: -208M Q4 '18: -2.9B Q1 '19: -105M Q2 '19: -689M Q3 '19: -314M Q4 '19: 110M Q1 '20: 69M Q2 '20: 140M Q3 '20: -4.3B Q4 '20: 150M Q1 '21: 77M Q2 '21: 207M Q3 '21: 292M Q1 '22: -955M Q2 '22: -232M Q3 '22: 56M Q4 '22: -1.3B Q1 '23: -220M Q2 '23: -872M Q3 '23: 69M Q4 '23: 464M Q1 '24: -139M Q2 '24: -846M Q3 '24: -437M Q4 '24: -217M Q1 '25: 214M Q2 '25: 282M Q3 '25: 433M Q4 '25: 480M Q1 '26: 369M Q2 '26: -576M Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Cost of Revenue Quarterly

0 1.5B 3B 4.5B Q3 '16: 2.8B Q4 '16: 3.1B Q1 '17: 2.8B Q2 '17: 2.9B Q3 '17: 3B Q4 '17: 2.6B Q1 '18: 2.8B Q2 '18: 2.7B Q3 '18: 2.6B Q4 '18: 2B Q1 '19: 2.3B Q2 '19: 2.3B Q3 '19: 2.3B Q4 '19: 2.5B Q1 '20: 2.3B Q2 '20: 2.1B Q3 '20: 2.1B Q4 '20: 2.4B Q1 '21: 2.1B Q2 '21: 2B Q3 '21: 2.1B Q4 '21: 2B Q1 '22: 1.9B Q2 '22: 2B Q3 '22: 1.9B Q4 '22: 2.1B Q1 '23: 2.1B Q2 '23: 2.1B Q3 '23: 2B Q4 '23: 2B Q1 '24: 2B Q2 '24: 2.1B Q3 '24: 2.2B Q4 '24: 2.1B Q1 '25: 2B Q2 '25: 2.1B Q3 '25: 2.2B Q4 '25: 2.1B Q1 '26: 2B Q2 '26: 2B Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating Cash Flow Quarterly

-600M 0 600M 1.2B 1.8B Q3 '16: 1.5B Q4 '16: 1.4B Q1 '17: 136M Q2 '17: 435M Q3 '17: 795M Q4 '17: 859M Q1 '18: 1.5B Q2 '18: 162M Q3 '18: 421M Q4 '18: 367M Q1 '19: 112M Q2 '19: -227M Q3 '19: 325M Q4 '19: 538M Q1 '20: 305M Q2 '20: 273M Q3 '20: 307M Q4 '20: 331M Q1 '21: -405M Q2 '21: 218M Q3 '21: 529M Q4 '21: 456M Q1 '22: -49M Q2 '22: 123M Q3 '22: 543M Q4 '22: 973M Q1 '23: -145M Q2 '23: 324M Q3 '23: 5M Q4 '23: 1.2B Q1 '24: -124M Q2 '24: 103M Q3 '24: 693M Q4 '24: 575M Q1 '25: -105M Q2 '25: 227M Q3 '25: 369M Q4 '25: 1.2B Q1 '26: -40M Q2 '26: 411M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Free Cash Flow Quarterly

-1B -500M 0 500M 1B 1.5B Q3 '16: 1.2B Q4 '16: 1.1B Q1 '17: -66M Q2 '17: 242M Q3 '17: 583M Q4 '17: 592M Q1 '18: 1.3B Q2 '18: 26M Q3 '18: 282M Q4 '18: 154M Q1 '19: -13M Q2 '19: -339M Q3 '19: 156M Q4 '19: 419M Q1 '20: 177M Q2 '20: 142M Q3 '20: 164M Q4 '20: 155M Q1 '21: -555M Q2 '21: 105M Q3 '21: 383M Q4 '21: 303M Q1 '22: -206M Q2 '22: -4M Q3 '22: 421M Q4 '22: 831M Q1 '23: -284M Q2 '23: 205M Q3 '23: -144M Q4 '23: 1.1B Q1 '24: -248M Q2 '24: 6M Q3 '24: 545M Q4 '24: 446M Q1 '25: -232M Q2 '25: 131M Q3 '25: 233M Q4 '25: 1B Q1 '26: -208M Q2 '26: 307M Q3 '17 Q4 '18 Q1 '20 Q2 '21 Q3 '22 Q4 '23 Q1 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 500M 1B 1.5B Q2 '13: 849M Q3 '13: 846M Q1 '14: 852M Q2 '14: 857M Q3 '14: 861M Q1 '15: 859M Q2 '15: 859M Q3 '15: 862M Q1 '16: 920M Q2 '16: 920M Q3 '16: 984M Q1 '17: 1B Q2 '17: 1B Q3 '17: 1B Q1 '18: 1B Q2 '18: 1B Q3 '18: 1B Q1 '19: 1.1B Q2 '19: 1.1B Q3 '19: 1.1B Q1 '20: 1.1B Q2 '20: 1.1B Q3 '20: 1.1B Q1 '21: 1.1B Q2 '21: 1.1B Q3 '21: 1.1B Q1 '22: 1.1B Q2 '22: 1.1B Q3 '22: 1.1B Q1 '23: 1.1B Q2 '23: 1.1B Q3 '23: 1.1B Q1 '24: 1.1B Q2 '24: 1.1B Q3 '24: 1.1B Q1 '25: 1.2B Q2 '25: 1.2B Q3 '25: 1.2B Q1 '26: 1.2B Q2 '26: 1.2B Q3 '14 Q2 '16 Q1 '18 Q3 '19 Q2 '21 Q1 '23 Q3 '24 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q1 '15: 3.21 Q2 '15: 2.97 Q3 '15: 2.07 Q4 '15: 1.83 Q1 '16: 1.93 Q4 '16: 0.07 Q1 '17: 0.10 Q2 '17: -6.04 Q3 '17: -5.87 Q4 '17: -16.26 Q1 '18: -15.80 Q2 '18: -10.10 Q3 '18: -10.89 Q4 '18: -2.33 Q1 '19: -3.46 Q2 '19: -3.85 Q3 '19: -3.87 Q4 '19: -0.92 Q1 '20: -0.76 Q2 '20: 0.00 Q3 '20: -3.68 Q4 '20: -3.64 Q1 '21: -3.63 Q2 '21: -3.57 Q3 '21: 0.66 Q4 '22: -2.19 Q1 '23: -1.53 Q2 '23: -2.10 Q3 '23: -2.09 Q4 '23: -0.50 Q1 '24: -0.42 Q2 '24: -0.39 Q3 '24: -0.84 Q4 '24: -1.45 Q1 '25: -1.15 Q2 '25: -0.16 Q3 '25: 0.60 Q4 '25: 1.20 Q1 '26: 1.33 Q2 '26: 0.60 Q1 '16 Q4 '17 Q1 '19 Q2 '20 Q3 '21 Q4 '23 Q1 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.